These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7378302)

  • 1. An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigen.
    Reisner HM; Strand EA; Chung KS; Roberts HR
    Br J Haematol; 1980 Feb; 44(2):313-21. PubMed ID: 7378302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor IX antigen by a rapid staphylococcal protein A-membrane binding radioimmunoassay: results in haemophilia B patients and carriers and in fetal samples.
    Suzuki LA; Thompson AR
    Br J Haematol; 1982 Apr; 50(4):673-82. PubMed ID: 7066213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of heterogeneity of haemophilia B for the detection of carriers.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):310-8. PubMed ID: 6157611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodies.
    Theodorsson B; Hedner U; Nilsson IM; Kisiel W
    Blood; 1983 May; 61(5):973-81. PubMed ID: 6338979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.
    Boylan B; Rice AS; Neff AT; Manco-Johnson MJ; Kempton CL; Miller CH;
    J Thromb Haemost; 2016 Oct; 14(10):1931-1940. PubMed ID: 27501440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory prediction of the carrier state in hemophilia B: role of replication of assays.
    Lipworth L; Tiarks CY; Rice CA; Pechet L
    Am J Clin Pathol; 1979 Dec; 72(6):1000-4. PubMed ID: 391020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic studies of factor IX (Christmas factor). II. Immunoradiometric assay of factor IX antigen.
    Yang HC
    Br J Haematol; 1978 Jun; 39(2):215-24. PubMed ID: 678474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunological method for detection of the carrier of hemophilia B.
    Matsuoka M; Ito M; Takahashi K; Sakuragawa N
    Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an occult inhibitor to factor IX in a haemophilia B patient.
    Miller CH; Orstavik KH; Hilgartner MW
    Br J Haematol; 1985 Oct; 61(2):329-38. PubMed ID: 4041376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B.
    Thompson AR
    Thromb Res; 1977 Aug; 11(2):193-203. PubMed ID: 905971
    [No Abstract]   [Full Text] [Related]  

  • 18. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI; Carmona E; Aznar JA; Peiró A; Sánchez-Cuenca JM
    Thromb Haemost; 1985 Aug; 54(2):377-80. PubMed ID: 3936211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of factor IX antigen and coagulant in hemophilia B patients and carriers.
    Pechet L; Tiarks CY; Stevens J; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):465-77. PubMed ID: 425061
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods for the detection of haemophilia carriers: a memorandum.
    Bull World Health Organ; 1977; 55(6):675-702. PubMed ID: 304395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.